gp100 Melanoma Antigen

"gp100 Melanoma Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A melanosome-associated protein that plays a role in the maturation of the MELANOSOME.

Descriptor ID

D058951

MeSH Number(s)

D12.776.543.306

D12.776.624.301.500

D23.050.285.439.500

Concept/Terms

gp100 Melanoma Antigen

Below are MeSH descriptors whose meaning is more general than "gp100 Melanoma Antigen".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
gp100 Melanoma Antigen [D12.776.543.306]
Neoplasm Proteins [D12.776.624]
Melanoma-Specific Antigens [D12.776.624.301]
gp100 Melanoma Antigen [D12.776.624.301.500]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Neoplasm [D23.050.285]
Melanoma-Specific Antigens [D23.050.285.439]
gp100 Melanoma Antigen [D23.050.285.439.500]

Below are MeSH descriptors whose meaning is related to "gp100 Melanoma Antigen".

Below are MeSH descriptors whose meaning is more specific than "gp100 Melanoma Antigen".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "gp100 Melanoma Antigen" by people in Harvard Catalyst Profiles by year, and whether "gp100 Melanoma Antigen" was a major or minor topic of these publication.

Bar chart showing 21 publications over 14 distinct years, with a maximum of 3 publications in 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2000	0	2	2
2001	0	1	1
2002	0	1	1
2003	0	3	3
2004	0	1	1
2005	0	1	1
2006	0	2	2
2007	0	2	2
2008	0	2	2
2010	0	2	2
2013	1	0	1
2014	0	1	1
2019	1	0	1

Below are the most recent publications written about "gp100 Melanoma Antigen" by people in Profiles.

Non-Synonymous variants in premelanosome protein (PMEL) cause ocular pigment dispersion and pigmentary glaucoma. Hum Mol Genet. 2019 04 15; 28(8):1298-1311.

View in: PubMed
Iron upregulates melanogenesis in cultured retinal pigment epithelial cells. Exp Eye Res. 2014 Nov; 128:92-101.

View in: PubMed
Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20). Ann Oncol. 2013 Oct; 24(10):2694-2698.

View in: PubMed
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature. 2012 Oct 18; 490(7420):412-6.

View in: PubMed
Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies. J Immunother. 2011 May; 34(4):343-52.

View in: PubMed
Rab7 is a critical mediator in vesicular transport of tyrosinase-related protein 1 in melanocytes. J Dermatol. 2011 May; 38(5):432-41.

View in: PubMed
Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function. Cancer Res. 2010 Jul 01; 70(13):5213-9.

View in: PubMed
No correlation between clinical response to CTLA-4 blockade and presence of NY-ESO-1 antibody in patients with metastatic melanoma. J Immunother. 2009 Oct; 32(8):884-5.

View in: PubMed
Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen. Int Immunol. 2009 Feb; 21(2):155-65.

View in: PubMed
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions. Mod Pathol. 2008 Sep; 21(9):1121-9.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Immunother
Hum Mol Genet
Ann Oncol
J Immunol
Cancer Res
Clin Cancer Res
Cancer Cell
Br J Cancer
Arch Dermatol
Am J Pathol